NIH-funded study of Avastin and Lucentis examines their effects at five years.
Atlanta, GA–(ENEWSPF)–May 3, 2016. In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National Eye Institute (NEI) at…
